Weiss v. American Academy of Ophthalmology, Inc.

District Court, N.D. California·Decided January 15, 2021·No. 3:20-cv-08124·Unknown

Opinion

JEFFREY N WEISS, Case No. 20-cv-08124-CRB

Plaintiff, ORDER DENYING MOTION FOR A v. PRELIMINARY INJUNCTION AND GRANTING MOTION TO DISMISS OPHTHALMOLOGY, INC., Defendant. Plaintiff Dr. Jeffrey Weiss is suing Defendant American Academy of Ophthalmology, Inc. (AAO). Dr. Weiss alleges that AAO has been conducting an ethics investigation of Dr. Weiss without following AAO’s established procedures, and that his potential termination or suspension from membership in AAO would thus violate his “right to fair procedure” under California law. Dr. Weiss has moved for a preliminary injunction that would enjoin AAO from taking any further action in its investigation. AAO has moved to dismiss this suit as unripe and for failure to state a claim for which relief may granted. Because the Court lacks jurisdiction over Dr. Weiss’s right to fair procedure claim, and Dr. Weiss’s complaint does not state any other claim for which relief may be granted, the Court denies Dr. Weiss’s motion for a preliminary injunction and grants AAO’s motion to dismiss with leave to amend. The Court determines that there is no need for oral argument. Dr. Weiss, a Florida resident, is an ophthalmologist and a member of AAO. See various medical conditions, including those causing vision impairment and blindness.” Id. ¶ 8. In 2013, Dr. Weiss designed a study “involving the isolation of autologous bone marrow derived stem cells . . . and the transfer of those cells to the eyes” to restore sight to visually impaired patients. Id. ¶ 14. In 2015, Dr. Weiss designed a second study “to continue to investigate the benefits” of this bone marrow derived stem cell treatment methodology. Id. ¶ 15. Dr. Weiss alleges that both studies were annually reviewed and approved by the “Institutional Review Board (IRB) maintained by the International Cellular Medical Society.” Id. ¶ 16. AAO’s “Code of Ethics” includes “Principles of Ethics,” “Rules of Ethics,” and “Administrative Procedures.” Id. ¶ 10. Under the Administrative Procedures, an Ethics Committee has authority to investigate whether an AAO member has violated the Rules of Ethics. Id. ¶ 11. The Committee must investigate “objectively and without prejudgment,” and the AAO member under investigation must receive notice of “the factual details of the challenge with sufficient particularity to permit the . . . member to respond to the challenge and prepare any necessary defense.” Id. ¶ 12. Dr. Weiss alleges that on July 24, 2017, the AAO Ethics Committee informed Dr. Weiss that it was concerned about his studies and asked Dr. Weiss to answer ten questions about them. See id. ¶ 18. After Dr. Weiss responded with answers, the Committee informed Dr. Weiss that it wished to review his research to assess his compliance with the AAO’s Rules of Ethics. Id. ¶ 20. AAO was concerned about potential violations of several Rules of Ethics, including Rule 3. Id. ¶¶ 20–21. At the time, Rule 3 required that any research be approved by “appropriate review mechanisms.” Id. ¶ 22. Dr. Weiss explained to AAO that his research was approved by IRB. Id. Dr. Weiss alleges that on May 1, 2018, the Committee “began a formal challenge into Dr. Weiss’s compliance” with the Code of Ethics. Id. ¶ 24. The Committee expressed concern about “research protocols,” the “scientific basis for the studies,” “participation fees,” and “advertisement” of the studies. Id. The Challenge also requested “objective was unable to understand the nature of the charges against him and requested that the Committee disclose the factual details of the Challenge with enough particularity for him to respond and prepare any necessary defense. Id. ¶ 25. Dr. Weiss alleges that the Committee “did not disclose the factual basis of the challenge” in response. Id. ¶ 26. Although the Committee stated that it was not challenging the “scientific basis” of the research, it requested specific information relating to the results of the studies. Id. ¶ 27. Dr. Weiss turned over more than 40,000 pages of raw patient data, but did not send the Committee a requested “dataset analysis.” Id. ¶¶ 27, 28. The Committee has not made any final decisions regarding the Challenge. See id. ¶¶ 30–34. On October 22, 2020, the Committee informed Dr. Weiss that it would hold a virtual hearing on November 21, 2020 to address Dr. Weiss’s alleged non-observance of two Rules of Ethics (including Rule 3). Id. ¶ 31. Dr. Weiss alleges that the Committee intended to conduct a “sham hearing” and then “overrule the wisdom and reject the process of the IRB” without the authority to do so. Id. The Complaint does not describe any events that occurred during or after this planned hearing. Dr. Weiss maintains that he has not violated any Rules of Ethics, and alleges that “by pursuing this inquisition, the Committee has signaled that the outcome of the process is predetermined—Dr. Weiss will be found ‘guilty’—but that it must go through the motions of feigning a ‘fair’ trial first.” Id. ¶ 30. Although Dr. Weiss does not allege that the Committee has taken direct action against him as a result of its investigation, Dr. Weiss alleges that the Committee has nonetheless “mortally damaged” his medical practice by failing to follow its own confidentiality rules. Id. ¶ 33. On November 18, 2020, Weiss sued AAO, alleging that AAO is violating Dr. Weiss’s “right of fair procedure” under California law. See id. at 11. On December 11, 2020, Dr. Weiss moved for a preliminary injunction. See Mot. for Injunction (dkt. 14). Dr. Weiss argues that under California Law, AAO cannot terminate or suspend his membership “in an arbitrary manner that did not follow the organization’s established the ethics inquiry. See Mot. for Injunction at 5. AAO has moved to dismiss. See Mot. to Dismiss (dkt. 17). A. Jurisdiction Under Article III of the U.S. Constitution, the Court has jurisdiction over only “cases” and “controversies.” U.S. Const. Art. III. If a plaintiff lacks standing, there is no Article III case or controversy, and the Court thus lacks jurisdiction. See, e.g., Spokeo, Inc. v. Robins, 136 S. Ct. 1540, 1547 (2016). To have standing, a plaintiff must establish (1) that he has suffered an injury in fact, (2) that his injury is fairly traceable to a defendant’s conduct, and (3) that his injury would likely be redressed by a favorable decision. See Lujan v. Defenders of Wildlife, 504 U.S. 555, 560–61 (1992). To establish the first of these elements, a plaintiffs must demonstrate “‘an invasion of a legally protected interest’ that is ‘concrete and particularized’ and ‘actual or imminent, not conjectural or hypothetical.’” Spokeo, 136 S. Ct. at 1548 (quoting Lujan, 504 U.S. at 560). Similarly, “ripeness doctrine is drawn both from Article III limitations on judicial power and from prudential reasons for refusing to exercise jurisdiction.” Nat’l Park Hospitality Ass’n v. Dep’t of Interior, 538 U.S. 803, 808 (2003) (citation omitted). Ripeness is “designed to separate matters that are premature for review because the injury is speculative and may never occur from those cases that are appropriate for federal court action.” Wolfson v. Brammer, 616 F.3d 1045, 1057 (9th Cir. 2010) (citation omitted). “Ripeness has both constitutional and prudential components.” Id. The constitutional component “overlaps” with Article III’s “injury in fact” analysis, and requires determining “whether the issues presented are definite and concrete, not hypothetical or abstract.” Id. (citation omitted). The prudential component requires considering “the fitness of the issues for judicial decision and the hardship to the parties of withholding court consideration.” Id. (quoting Abbot Labs v. Gardner,

Weiss v. American Academy of Ophthalmology, Inc., (N.D. Cal. 2021).

Weiss v. American Academy of Ophthalmology, Inc. (Weiss v. American Academy of Ophthalmology, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Maryland Casualty Co. v. Pacific Coal & Oil Co.
312 U.S. 270 (Supreme Court, 1941)
Abbott Laboratories v. Gardner
387 U.S. 136 (Supreme Court, 1967)
Lujan v. Defenders of Wildlife
504 U.S. 555 (Supreme Court, 1992)
Tellabs, Inc. v. Makor Issues & Rights, Ltd.
551 U.S. 308 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Wolfson v. Brammer
616 F.3d 1045 (Ninth Circuit, 2010)
Malloy v. WM Specialty Mortgage LLC
512 F.3d 23 (First Circuit, 2008)
Barker v. Lull Engineering Co.
573 P.2d 443 (California Supreme Court, 1978)
Leadsinger, Inc. v. BMG Music Publishing
512 F.3d 522 (Ninth Circuit, 2008)
DeYoung v. City of San Diego
147 Cal. App. 3d 11 (California Court of Appeal, 1983)
Spokeo, Inc. v. Robins
578 U.S. 330 (Supreme Court, 2016)